Fortress Biotech Files 2024 Annual Report
Ticker: FBIOP · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1429260
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
FBIO filed its 2024 10-K. All systems go.
AI Summary
Fortress Biotech, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, operating in pharmaceutical preparations, reported key financial figures and outlined its business activities. The filing details its corporate structure, business address in Bay Harbor Islands, FL, and its history, including a former name change from Coronado Biosciences Inc. on March 10, 2008.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Fortress Biotech's financial health, operational performance, and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — The company operates in the highly regulated and competitive pharmaceutical industry, which carries inherent risks related to drug development, clinical trials, and market approval.
Key Numbers
- 3427138 — Shares Outstanding (Indicates the total number of shares available for trading.)
- 15093053 — Total Assets (Represents the company's total resources as of the fiscal year end.)
- 27908839 — Total Liabilities (Shows the company's total obligations as of the fiscal year end.)
Key Players & Entities
- Fortress Biotech, Inc. (company) — Filer of the 10-K
- December 31, 2024 (date) — Fiscal year end
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- Bay Harbor Islands, FL (location) — Business and mailing address
- Coronado Biosciences Inc. (company) — Former company name
- March 10, 2008 (date) — Date of former company name change
FAQ
What is Fortress Biotech's primary business activity?
Fortress Biotech, Inc. is primarily involved in pharmaceutical preparations, as indicated by its Standard Industrial Classification code 2834.
When did Fortress Biotech change its name from Coronado Biosciences Inc.?
The company changed its name from Coronado Biosciences Inc. on March 10, 2008.
Where is Fortress Biotech's principal place of business located?
Fortress Biotech's business and mailing address is 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154.
What is the fiscal year end for this 10-K filing?
The fiscal year end for this 10-K filing is December 31, 2024.
What are some of the specific entities or warrants mentioned in relation to Fortress Biotech's business activities?
The filing mentions entities such as Ur1 Therapeutics Inc., Avenue Therapeutics Inc., and Mustang Therapeutics Inc., along with various types of warrants including Concurrent Private Placement Warrants, Common Stock Warrants, Series One Warrants, Series Two Warrants, and Series Three Warrants.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Fortress Biotech, Inc. (FBIOP).